Pneumococcal vaccine is particularly effective in preventing meningitis and septicemia and the present vaccine available contains serotypes of virulent bacteria. A 23-valent vaccine increases efficacy by 28%.
Pneumococcal vaccine is currently recommended for children with sickle cell disease, children who have undergone splenectomy and children with nephrotic syndrome on steroids.
Pneumococcal vaccine is currently recommended for children with sickle cell disease, children who have undergone splenectomy and children with nephrotic syndrome on steroids.